PROTO SCRIPT PHARMACEUTICAL CORP — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2015)

$881.4K

Cash Flows from Operating Activities (FY2015)

$38.1K

Source: PROTO SCRIPT PHARMACEUTICAL CORP 10-K/A filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.